Safety, tolerability and activity of gefitinib (ZD1839) in combination with tamoxifen in ovarian cancer patients refractory to platinum-taxane based therapy – a Phase-II study of the Ovarian Cancer Study Group (AGO Ovar 2.6)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 5016-5016 ◽  
Author(s):  
S. Loibl ◽  
A. Du Bois ◽  
J. Pfisterer ◽  
J. Huober ◽  
H.-J. Lueck ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Study Group ◽  
Cancer Study ◽  
Cancer Study Group

A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: A report from the Childrens Cancer Study Group

1990 ◽  
Vol 9 (1) ◽  
pp. 69-76 ◽  
Author(s):  
Lawrence J. Ettinger ◽  
Ning Ru ◽  
Mark Krailo ◽  
Kathleen S. Ruccione ◽  
William Krivit ◽  
...  
Keyword(s):  
Brain Tumors ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Study Group ◽  
Cancer Study ◽  
Primary Brain Tumors ◽  
Cancer Study Group

scholarly journals Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11

2018 ◽  
Vol 21 (5) ◽  
pp. 802-810 ◽  
Author(s):  
Hyeong Su Kim ◽  
Min-Hee Ryu ◽  
Dae Young Zang ◽  
Sook Ryun Park ◽  
Boram Han ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Study Group ◽  
Cancer Study ◽  
Cancer Study Group
Sign in / Sign up

Export Citation Format

Share Document